Drugs of abuse public hearing
This article was originally published in The Gray Sheet
Input on a March 5 proposed rule to downclassify from Class III to Class I over-the-counter urine sample collection systems for drugs-of-abuse testing will be sought at a June 19 meeting in Rockville, Maryland. William Schultz, FDA deputy commissioner for policy, will direct the meeting. For more information contact the device center's Steven Gutman at 301/594-3084
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.